115 related articles for article (PubMed ID: 37146214)
1. Management of Localized Small- and Large-Cell Pancreatic Neuroendocrine Carcinoma in the National Cancer Database.
Sugawara T; Rodriguez Franco S; Franklin O; Kirsch MJ; Colborn KL; Del Chiaro M; Schulick RD
J Am Coll Surg; 2023 Sep; 237(3):515-524. PubMed ID: 37146214
[TBL] [Abstract][Full Text] [Related]
2. Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis.
Kaslow SR; Vitiello GA; Prendergast K; Hani L; Cohen SM; Wolfgang C; Berman RS; Lee AY; Correa-Gallego C
Ann Surg Oncol; 2022 Jun; 29(6):3522-3531. PubMed ID: 35246811
[TBL] [Abstract][Full Text] [Related]
3. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
4. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer.
Bergquist JR; Ivanics T; Shubert CR; Habermann EB; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB; Truty MJ
Ann Surg Oncol; 2017 Jun; 24(6):1731-1738. PubMed ID: 28070725
[TBL] [Abstract][Full Text] [Related]
5. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early-stage large-cell neuroendocrine carcinoma.
Andreetti C; Ibrahim M; Gagliardi A; Poggi C; Maurizi G; Armillotta D; Peritone V; Teodonio L; Rendina EA; Venuta F; Anile M; Natale G; Santini M; Fiorelli A
Thorac Cancer; 2022 Apr; 13(7):900-912. PubMed ID: 35170859
[TBL] [Abstract][Full Text] [Related]
12. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.
Altman AM; Wirth K; Marmor S; Lou E; Chang K; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Ann Surg Oncol; 2019 Nov; 26(12):4108-4116. PubMed ID: 31313044
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors.
Sugawara T; Rodriguez Franco S; Kirsch MJ; Colborn KL; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Del Chiaro M; Schulick RD
JAMA Netw Open; 2023 Mar; 6(3):e234096. PubMed ID: 36976561
[TBL] [Abstract][Full Text] [Related]
14. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy.
Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M
JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190
[TBL] [Abstract][Full Text] [Related]
15. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.
de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
[TBL] [Abstract][Full Text] [Related]
16. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Kotake M; Imai H; Kaira K; Endoh H; Yamada Y; Kaburagi T; Kiyoshima M; Sugiyama T; Nakamura Y; Kasai T; Matsuguma H; Minemura H; Kanazawa K; Suzuki H; Fujita A; Minato K
Chemotherapy; 2022; 67(3):142-151. PubMed ID: 35313303
[TBL] [Abstract][Full Text] [Related]
18. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer.
Zhang C; Wu R; Smith LM; Baine M; Lin C; Reames BN
Am J Surg; 2022 Jul; 224(1 Pt A):51-57. PubMed ID: 34973686
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X
Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
